Igcip Eye/Ear Drops contain Ciprofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic effective against a variety of gram-positive and gram-negative bacteria. This ophthalmic and otic formulation is indicated for the treatment of bacterial infections of the eye and ear, including conjunctivitis, keratitis, blepharitis, otitis externa, and otitis media caused by susceptible organisms. Ciprofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, leading to bacterial cell death. Igcip Eye/Ear Drops provide targeted antimicrobial activity with minimal systemic absorption, reducing the risk of systemic side effects. The solution is sterile, preservative-containing, and designed for topical application to the affected eye or ear. Dosage and duration of therapy should be determined by a healthcare professional based on the severity and type of infection. Patients should be advised to avoid contaminating the dropper tip and to complete the full course of treatment to prevent resistance development. Common side effects may include transient burning or stinging upon instillation. Use is contraindicated in individuals with known hypersensitivity to ciprofloxacin or other quinolones. Caution is advised in patients with a history of hypersensitivity reactions to fluoroquinolones.